Mushroom-based products, particularly gummies and chocolates, have surged in popularity since 2023, marketed as either health supplements or hallucinogenic psychedelics. Notable varieties include Amanita muscaria, which contains ibotenic acid and muscimol, and Psilocybe cubensis, known for its psilocybin content. However, these products are associated with serious health risks, including hallucinations, anxiety, nausea, and even seizures, with recent reports of at least five hospitalizations in Virginia and 130 cases nationally linked to their consumption.
Investigations have revealed that many mushroom gummies contain undisclosed and potentially harmful substances, including synthetic psilocybin and stimulants like caffeine and kratom. The FDA has issued recalls for certain products due to these dangerous ingredients, highlighting the unregulated nature of the market. Consumers are advised to be cautious, verify product contents, and report any adverse effects to health authorities.